Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 1089, pseudogene (RNU6-1089P)
- Target
- RNU6-1089P
- Molecular classification
- Pseudogene, Small nuclear RNA (snRNA)-derived pseudogene, Non-coding RNA pseudogene
01
Overview
**RNA, U6 small nuclear 1089, pseudogene (RNU6-1089P)** is a human non-coding RNA locus classified as a pseudogene, related to the U6 small nuclear RNA (snRNA) family[5]. U6 snRNA itself is an essential component of the spliceosome involved in pre-mRNA splicing[1][3]. Pseudogenes like RNU6-1089P do not encode functional RNAs or proteins but may still be transcribed and play roles in post-transcriptional regulation or gene silencing through siRNA or ceRNA mechanisms[4][6][10]. RNU6-1089P is not considered a therapeutic drug target and has no established direct functional, disease, or biomarker associations. It is one of many U6 snRNA pseudogenes present in the human genome, thought to arise from duplication or retrotransposition events, and may have a role in regulating gene expression or genome evolution, but these functions are not fully characterized[7][10].
- Other names
- RNU6-1089PRNA, U6 Small Nuclear 1089, Pseudogene
02
Mechanism of action
None (no direct drug-targeted mechanism; potential indirect regulation via pseudogene-derived RNA products)
03
Biological functions
Possible regulation of gene expression via RNA interference pathways (e.g., acting as a source for small interfering RNAs or serving as competing endogenous RNAs)Potential production of lncRNAs that can regulate parental or related genesNo known canonical function as a protein or classical RNA
04
Disease associations
Other (Possible regulatory functions, but no established role in diseases such as cancer, inflammation, or neurodegeneration as of current evidence)
Beyond the preview
Go deeper on RNA, U6 small nuclear 1089, pseudogene (RNU6-1089P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, U6 small nuclear 1089, pseudogene (RNU6-1089P).